Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | HPGD | P15428 | 6/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24823396 | 0.85 | NPC1 (0.42) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| Bromide SCHEMBL29010815 | 0.84 | NPC1 (0.42) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| Bromide SCHEMBL29010830 | 0.84 | NPC1 (0.42) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| Bromide SCHEMBL30310971 | 0.84 | NPC1 (0.42) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| Bromide SCHEMBL31391625 | 0.84 | TARBP2 (0.36) | LMNATDP1HSD17B10KDM4EMAPT | |
| SCHEMBL24823310 | 0.81 | MAPT (0.42) | LMNASMN1; SMN2KDM4ETP53MAPT | |
| Bromide SCHEMBL30310918 | 0.81 | TARBP2 (0.37) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| Bromide SCHEMBL29010847 | 0.81 | TARBP2 (0.37) | LMNATDP1SMN1; SMN2HSD17B10KDM4E | |
| SCHEMBL24824325 | 0.81 | HTR1D (0.36) | LMNATDP1KDM4EALDH1A1HPGD | |
| Bromide SCHEMBL30311003 | 0.81 | MAPT (0.42) | LMNASMN1; SMN2KDM4ETP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230021669-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | The National Institutes of Pharmaceutical R&D Co., Ltd. (CN) | 2023-01-26 | — | — | US | disclosed |
| WO-2021136244-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 中国医药研究开发中心有限公司 | 2021-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230021669-A1 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | CYP4A11, CYP4F11, CYP11B2 | LMNA 1304/4885TDP1 1427/4885SMN1; SMN2 3789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.